Changes to the newborn outcomes solution reflect feedback from users and include improvements for laboratory users and changes to data entry pages for laboratory and clinical (nurse/medical) users.
Emma is a registered midwife who began her career in screening in 2009 as a trust antenatal and newborn screening coordinator. She is currently working as a clinical project lead for the NHS Sickle Cell and Thalassaemia Screening Programme, on secondment from her role as a senior quality assurance advisor in the south east of England. In 2018, Emma completed an MSc in Public Health and Management at the University of Brighton.
The newborn outcomes (NBO) solution is a web-based system for referring newborn babies who screen positive for sickle cell disease (SCD) and thalassaemia.
The newborn outcomes solution IT system is now live in all newborn blood spot laboratories.
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021